This mechanism, however, would not explain the inhibition of LPLA2 by compounds that cause phospholipidosis but lack a functional group that would be protonated at lysosomal pH including fosinopril, mitotane, and mannitol. This evidence concerns the gene PLA2G15 and lysosomal storage disease.